Previous 10 | Next 10 |
2024-04-16 14:16:55 ET Summary Just as the "Magnificent 7" stocks lead returns and headlines in US markets, an 11 stock basket called "GRANOLAS" have been called Europe's growth leaders. Here I run a head-to-head comparison using the Magnificent 7 as a proxy for the Invesco QQQ ET...
2024-04-12 14:12:23 ET Summary Zentalis Pharmaceuticals, Inc. expects final results from phase 1b study, using azenosertib + gemcitabine for the treatment of patients with osteosarcoma, in the 1st half of 2024. In a phase 1 study, using monotherapy azenosertib for 19 patients with...
2024-04-11 10:40:00 ET Summary Aristotle Capital Management is an independent/employee-owned investment management organization that specializes in equity and fixed income portfolio management for institutional and advisory clients worldwide. or the first quarter of 2024, Aristotl...
2024-04-09 10:03:48 ET More on Madrigal Pharmaceuticals Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly I...
2024-04-08 12:15:07 ET More on GSK, Pfizer, etc. Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns Pfizer Inc. (PFE) Leerink Partners Global Biopharma Conference 2024 - (Transcript) Pfizer: Seagen Acquisition Starting To Bear Fruit ...
2024-04-04 08:20:35 ET More on CureVac BV CureVac: No Momentum In Sight Seeking Alpha’s Quant Rating on CureVac BV Historical earnings data for CureVac BV Financial information for CureVac BV Read the full article on Seeking Alpha For f...
2024-04-03 17:45:51 ET French drugmaker Sanofi ( NASDAQ: SNY ) on Wednesday said it had agreed to settle about 4K lawsuits in all U.S. states outside of Del. over accusations that its Zantac heartburn drug caused cancer. ... Read the full article on Seeking Alpha Fo...
2024-04-02 03:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-30 10:50:43 ET More on GSK, Pfizer, etc. Sanofi: My Top Pick In Big Pharma Pfizer: Attractive Valuation And A Strong Pipeline Mitigate Patent Cliff Concerns Sanofi (SNY) Barclays 26th Annual Global Healthcare Conference (Transcript) Pfizer, Astellas f...
2024-03-25 13:47:00 ET Summary Boeing's top boss Dave Calhoun plans to step down at the end of the year. Mizuho turns cautious on the EV sector, downgrades Tesla, Rivian, and Nio. Look beyond the Magnificent 7 to the GRANOLAS in Europe - Goldman Sachs. Listen below o...
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline PLC Company Name:
GSK Stock Symbol:
NYSE Market:
Wednesday, GSK Plc (NYSE:GSK) reported first-quarter sales of $9.33 billion (7.4 billion Sterling Pounds), up 10% Y/Y and 13% e...
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASD...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...